TXT
Cabernet Study
A clinical study of a new investigational treatment for wet age-related macular degeneration (AMD).
The CABERNET study is now being conducted in medical sites around the world. Investigators are recruiting potential participants; up to 450 subjects will be involved over the next several years.

